# The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-improbable-targeted-therapy-kras-as-an-emerging-target-in-non-small-cell/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Ravi Salgia,Rebecca Pharaon,Isa Mambetsariev,Arin Nam,Martin Sattler |
| Citations | 161 |
| DOI | 10.1016/j.xcrm.2020.100186 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | http://www.cell.com/article/S266637912030241X/pdf |
| OpenAlex ID | https://openalex.org/W3125765158 |
| PMID | 33521700 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Isa Mambetsariev](https://scholariq.org/researchers/isa-mambetsariev/)

## Paper journal

- [Cell Reports Medicine](https://scholariq.org/journals/cell-reports-medicine/)

## Paper primary topic

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)

## Paper topics

- [Monoclonal and Polyclonal Antibodies Research](https://scholariq.org/topics/monoclonal-and-polyclonal-antibodies-research/)
- [Peptidase Inhibition and Analysis](https://scholariq.org/topics/peptidase-inhibition-and-analysis/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.